These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Independent review of interstitial lung disease associated with death in TRIBUTE (paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer. Yoneda KY; Shelton DK; Beckett LA; Gandara DR J Thorac Oncol; 2007 Jun; 2(6):537-43. PubMed ID: 17545850 [TBL] [Abstract][Full Text] [Related]
14. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Roubille C; Haraoui B Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065 [TBL] [Abstract][Full Text] [Related]
15. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer. Maitland ML; Wilcox R; Hogarth DK; Desai AA; Caligiuri P; Abrahams C; Salgia R Lung Cancer; 2006 Nov; 54(2):243-5. PubMed ID: 16949700 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and functional disorders in side effects of drugs on the lung]. Konietzko N Pneumologie; 1990 Feb; 44 Suppl 1():173-7. PubMed ID: 2195511 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight. Min JH; Lee HY; Lim H; Ahn MJ; Park K; Chung MP; Lee KS Cancer Chemother Pharmacol; 2011 Nov; 68(5):1099-109. PubMed ID: 21913033 [TBL] [Abstract][Full Text] [Related]
19. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Malik SW; Myers JL; DeRemee RA; Specks U Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1851-6. PubMed ID: 8970380 [TBL] [Abstract][Full Text] [Related]
20. [Respiratory side-effects of drugs]. van der Drift MA; Kaajan JP Ned Tijdschr Geneeskd; 2002 Jan; 146(4):145-50. PubMed ID: 11845561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]